Audrey Gueniche
Research Subjects
Audrey Gueniche has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Pichon
L'Oréal Research & Innovation Chevilly‐Larue France
2 shared publications - Alice Brule
L'Oréal Research & Innovation Chevilly‐Larue France
1 shared publication Annie Black
LANCÔME Levallois‐Peret France
1 shared publicationElodie Valverde
L'Oréal Research & Innovation Chevilly‐Larue France
1 shared publicationMarion Mesrobian
L'Oréal Research & Innovation Chevilly‐Larue France
1 shared publicationSybille De Bussy
L'Oréal Research & Innovation Chevilly‐Larue France
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by Wiley in International Journal of Cosmetic Science
The harnessing potential of carboxymethyl beta glucan: A driver of skin repair
Skin continually faces stresses that compromise its structure and barrier quality, impacting skin appearance and comfort. By sustaining the main biological process of epithelisation, we could improve skin repair, thus correcting skin appearance or discomfort. A stronger barrier will ultimately lead to improvement of the skin surface smoothness, fine lines and radiance. To bolster barrier function, the cohesion of the stratum corneum involving keratinocyte transglutaminase (TGK) and filaggrin (FLG) and the stratum granulosum via tight junction proteins, is critical. Carboxymethyl beta‐glucan (CM‐BG), a water‐soluble derivative of β‐glucan, has shown promise in skin repair and anti‐ageing applications. This study investigates its wound repair potential using in vitro assays and a 3D human full‐thickness wounded skin model. The effects of CM‐BG on various skin biological processes, including inflammation, differentiation and extracellular matrix remodelling, were investigated using a range of in vitro assays. Its potential to promote wound healing, epidermal recovery and barrier function was further assessed in a 3D reconstructed skin model. These comprehensive investigations revealed CM‐BG's multifaceted actions in skin biology. Findings showed CM‐BG selectively activates Dectin‐1 receptors in a concentration‐dependent manner. Furthermore, CM‐BG exhibited anti‐inflammatory properties by inhibiting key pro‐inflammatory mediators (PGE2, IL‐12/IL‐23p40, IL‐1β) while promoting the release of anti‐inflammatory cytokines IL‐10. Additionally, CM‐BG significantly enhanced the expression of TGK, tight junction proteins (Claudin‐1, Zonula occludens‐1 and Occludin) and collagen type I. A 3D skin wound healing model confirmed these findings. CM‐BG accelerated wound repair, reduced Transepidermal Water Loss and increased epidermal/dermal thickness in the wounded area. Additionally, post‐injury, CM‐BG also showed increased expression of key markers on the 3D reconstructed skin model. These results suggest CM‐BG is a valuable topical ingredient for promoting wound healing, skin repair and mitigating skin ageing by interacting with Dectin‐1 receptors, modulating inflammation, improving skin barrier function and boosting collagen production. Further clinical studies are warranted to confirm these promising findings.
- 22 June 2026
- Published by Wiley in International Journal of Cosmetic Science
Open AccessThe harnessing potential of carboxymethyl beta glucan: A driver of skin repair
Skin continually faces stresses that compromise its structure and barrier quality, impacting skin appearance and comfort. By sustaining the main biological process of epithelisation, we could improve skin repair, thus correcting skin appearance or discomfort. A stronger barrier will ultimately lead to improvement of the skin surface smoothness, fine lines and radiance. To bolster barrier function, the cohesion of the stratum corneum involving keratinocyte transglutaminase (TGK) and filaggrin (FLG) and the stratum granulosum via tight junction proteins, is critical. Carboxymethyl beta‐glucan (CM‐BG), a water‐soluble derivative of β‐glucan, has shown promise in skin repair and anti‐ageing applications. This study investigates its wound repair potential using in vitro assays and a 3D human full‐thickness wounded skin model. The effects of CM‐BG on various skin biological processes, including inflammation, differentiation and extracellular matrix remodelling, were investigated using a range of in vitro assays. Its potential to promote wound healing, epidermal recovery and barrier function was further assessed in a 3D reconstructed skin model. These comprehensive investigations revealed CM‐BG's multifaceted actions in skin biology. Findings showed CM‐BG selectively activates Dectin‐1 receptors in a concentration‐dependent manner. Furthermore, CM‐BG exhibited anti‐inflammatory properties by inhibiting key pro‐inflammatory mediators (PGE2, IL‐12/IL‐23p40, IL‐1β) while promoting the release of anti‐inflammatory cytokines IL‐10. Additionally, CM‐BG significantly enhanced the expression of TGK, tight junction proteins (Claudin‐1, Zonula occludens‐1 and Occludin) and collagen type I. A 3D skin wound healing model confirmed these findings. CM‐BG accelerated wound repair, reduced Transepidermal Water Loss and increased epidermal/dermal thickness in the wounded area. Additionally, post‐injury, CM‐BG also showed increased expression of key markers on the 3D reconstructed skin model. These results suggest CM‐BG is a valuable topical ingredient for promoting wound healing, skin repair and mitigating skin ageing by interacting with Dectin‐1 receptors, modulating inflammation, improving skin barrier function and boosting collagen production. Further clinical studies are warranted to confirm these promising findings.
- Open Access
- 3 May 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (5) , e70193
Efficacy in Clinical Studies of a Skin Care Serum Formula Containing 7 Short and Long Saccharides and Bacterial Fractions to Repair and Strengthen the Skin Barrier From Aggressions in Intense Conditions
Background: A healthy skin barrier is essential to protect against the entry of harmful substances or the loss of internal fluids, especially water and electrolytes. Various aggressions are known to weaken the skin barrier. Aims: To evaluate single or multiple applications of a serum formula designed to mitigate skin barrier dysfunction and improve recovery after exposure to three different external aggressions (including one cumulative aggression under intense conditions). Patients and Methods: Five single‐blind, controlled, intra‐individual clinical studies in healthy subjects evaluated the effect of serum formula vs. untreated skin after aggression with harsh cleanser, emery paper abrasion, or tape stripping followed by exposure to 4°C or 40°C. Skin barrier function was assessed by transepidermal water loss (TEWL) and skin pH. Results: After harsh cleanser aggression, significant improvements in pH recovery and TEWL were observed after serum application, vs. untreated control, indicating significantly faster skin barrier recovery. Similarly, after tape stripping followed by intense cold or hot conditions, barrier function recovery was also significantly faster with an application of serum versus untreated control. In addition, serum‐treated skin was more resistant against abrasion after serum treatment compared to the untreated control. Conclusions: The serum formula, containing a unique combination of seven short and long saccharides and bacterial fractions, helped repair and strengthen the skin barrier to protect against abrasion. Taken together, these studies showed improved skin barrier recovery after exposure to different types of aggression (harsh cleanser or cumulative aggression by tape stripping followed by intense cold or hot conditions).
- 3 May 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (5) , e70193
Open AccessEfficacy in Clinical Studies of a Skin Care Serum Formula Containing 7 Short and Long Saccharides and Bacterial Fractions to Repair and Strengthen the Skin Barrier From Aggressions in Intense Conditions
Background: A healthy skin barrier is essential to protect against the entry of harmful substances or the loss of internal fluids, especially water and electrolytes. Various aggressions are known to weaken the skin barrier. Aims: To evaluate single or multiple applications of a serum formula designed to mitigate skin barrier dysfunction and improve recovery after exposure to three different external aggressions (including one cumulative aggression under intense conditions). Patients and Methods: Five single‐blind, controlled, intra‐individual clinical studies in healthy subjects evaluated the effect of serum formula vs. untreated skin after aggression with harsh cleanser, emery paper abrasion, or tape stripping followed by exposure to 4°C or 40°C. Skin barrier function was assessed by transepidermal water loss (TEWL) and skin pH. Results: After harsh cleanser aggression, significant improvements in pH recovery and TEWL were observed after serum application, vs. untreated control, indicating significantly faster skin barrier recovery. Similarly, after tape stripping followed by intense cold or hot conditions, barrier function recovery was also significantly faster with an application of serum versus untreated control. In addition, serum‐treated skin was more resistant against abrasion after serum treatment compared to the untreated control. Conclusions: The serum formula, containing a unique combination of seven short and long saccharides and bacterial fractions, helped repair and strengthen the skin barrier to protect against abrasion. Taken together, these studies showed improved skin barrier recovery after exposure to different types of aggression (harsh cleanser or cumulative aggression by tape stripping followed by intense cold or hot conditions).